These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 6226386)

  • 1. [Effect of Japanese encephalitis virus-specific transfer factor on adherent inhibitory activity of peritoneal exudate cells].
    Wang FZ; Huang ZX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1983 Feb; 5(1):47-50. PubMed ID: 6226386
    [No Abstract]   [Full Text] [Related]  

  • 2. Specific inducer factor purified from splenocytic dialyzates of goat immunized with Japanese encephalitis virus.
    Song C; Li B; Wu W
    Acta Virol; 1993 Feb; 37(1):109. PubMed ID: 8105646
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on effect of a specific transfer factor on Japanese encephalitis virus infection in mice].
    Wang FZ; Huang ZX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1983 Apr; 5(2):102-6. PubMed ID: 6313238
    [No Abstract]   [Full Text] [Related]  

  • 4. Transfer in vivo of tuberculin hypersensitivity by sensitised lymphocytes.
    Fazio M; Calabrese F; Giacomasso S; Meina G; Negri L; Mastromatteo V
    Panminerva Med; 1993 Sep; 35(3):149-53. PubMed ID: 8090529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of T-cells in the mechanism of reactivity of the microplate leukocyte adherence inhibition assay.
    Raina S; Russo AJ; Jenkins D; Goldrosen MH
    Cancer Res; 1981 Oct; 41(10):3950-5. PubMed ID: 6456811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of mice against experimental Japanese encephalitis virus infections by neutralizing anti-glycoprotein E monoclonal antibodies.
    Gupta AK; Lad VJ; Koshy AA
    Acta Virol; 2003; 47(3):141-5. PubMed ID: 14658841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective mechanisms induced by a Japanese encephalitis virus DNA vaccine: requirement for antibody but not CD8(+) cytotoxic T-cell responses.
    Pan CH; Chen HW; Huang HW; Tao MH
    J Virol; 2001 Dec; 75(23):11457-63. PubMed ID: 11689627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of the tube leucocyte adherence inhibition (LAI) assay for immunogenetic studies in rats.
    Holán V; Hasek M
    Folia Biol (Praha); 1978; 24(6):410-1. PubMed ID: 365617
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuropathogenesis of Japanese encephalitis virus.
    Yasui K
    J Neurovirol; 2002 Dec; 8 Suppl 2():112-4. PubMed ID: 12491161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of murine bone marrow-derived dendritic cells loaded with inactivated virus as a vaccine against Japanese encephalitis virus.
    Li Y; Xu M; Chen L; Zhu J; Ye J; Liu X; Sun Y; Chen H; Cao S
    Vaccine; 2009 Oct; 27(43):6004-10. PubMed ID: 19665607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Japanese encephalitis DNA vaccine candidates expressing premembrane and envelope genes induce virus-specific memory B cells and long-lasting antibodies in swine.
    Konishi E; Yamaoka M; Kurane I; Mason PW
    Virology; 2000 Mar; 268(1):49-55. PubMed ID: 10683326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the hemocytometer and tube modifications of the leukocyte adherence inhibition assay -- II. Application of both modifications for detection of anti-tumor immunity in man.
    Schimke R; Holán V; Sibl O; Hasek M; Ambrosius H
    Neoplasma; 1981; 28(3):257-64. PubMed ID: 7027056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of mouse peritoneal exudate and associated leukocyte adherence inhibitory activity after intraperitoneal injection of either Bordetella pertussis or Corynebacterium parvum vaccines.
    Klein TW; Pross SH; Benjamin WR
    Infect Immun; 1978 Dec; 22(3):778-85. PubMed ID: 215552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterially expressed recombinant envelope protein domain III of Japanese encephalitis virus (rJEV-DIII) elicits Th1 type of immune response in BALB/c mice.
    Verma SK; Kumar S; Gupta N; Vedi S; Bhattacharya SM; Lakshmana Rao PV
    Vaccine; 2009 Nov; 27(49):6905-9. PubMed ID: 19761840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of pig sera for antibodies to Japanese encephalitis virus using a dot enzyme immunoassay and IgM capture ELISA: comparison with the hemagglutination inhibition and plaque reduction neutralization tests.
    Cardosa MJ; Hah FL; Choo BH; Padmanathan S
    Southeast Asian J Trop Med Public Health; 1993 Sep; 24(3):472-6. PubMed ID: 8160055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cell-mediated immunity in mice infected with Japanese encephalitis virus. I. Demonstration of cell-mediated immunity in vitro with macrophage migration and leukocyte adherence inhibition tests].
    Jia FL; Huang ZX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1983 Feb; 5(1):64-7. PubMed ID: 6313236
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunization with pseudotype baculovirus expressing envelope protein of Japanese encephalitis virus elicits protective immunity in mice.
    Li Y; Ye J; Cao S; Xiao S; Zhao Q; Liu X; Jin M; Chen H
    J Gene Med; 2009 Feb; 11(2):150-9. PubMed ID: 19040206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
    Guirakhoo F; Zhang ZX; Chambers TJ; Delagrave S; Arroyo J; Barrett AD; Monath TP
    Virology; 1999 May; 257(2):363-72. PubMed ID: 10329547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potency testing of inactivated tissue culture vaccine against Japanese encephalitis using antigen capture ELISA.
    Joshi AM; Walimbe AM; Banerjee K
    Acta Virol; 1997 Jun; 41(3):157-9. PubMed ID: 9385404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine.
    Beasley DW; Li L; Suderman MT; Guirakhoo F; Trent DW; Monath TP; Shope RE; Barrett AD
    Vaccine; 2004 Sep; 22(27-28):3722-6. PubMed ID: 15315852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.